Clinical Trial Update: Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients [NA]

View source ↗

Summary

A clinical trial evaluating whether adding local ablative treatment to systemic therapy improves outcomes for patients with stage IV non-small cell lung cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Non-small Cell Lung Cancer (NSCLC), Stage IV | NA | Status: RECRUITING